Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts ATHA Hot Sheet
Join SI Premium – FREE
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Progress Software completes $400M acquisition of Domo's data platform
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
